Source: Health Products Regulatory Authority (IE) Revision Year: 2009 Publisher: Reckitt Benckiser Ireland Ltd, 7 Riverwalk, Citywest Business Campus, Dublin 24
Dequadin 0.25 mg Lozenges.
| Pharmaceutical Form |
|---|
|
Lozenge. Round, pale-orange lozenges. |
Each lozenge contains 0.25 mg dequalinium chloride.
Excipient: Sunset yellow (E110) 0.4 mg per lozenge, Sucrose 998.925mg per lozenge, Liquid Glucose 50mg per lozenge.
For full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Dequalinium |
Dequalinum is an anti-infective and antiseptic agent belonging to the class of quaternary ammonium compounds. The primary mechanism of action is an increase in bacterial cell permeability and the subsequent loss of enzyme activity, finally resulting in cell death. |
| List of Excipients |
|---|
|
Sucrose |
PVC/PVDC blister strips sealed with aluminium foil enclosed in cardboard cartons to give packs of 20 or 40 lozenges.
Reckitt Benckiser Ireland Ltd, 7 Riverwalk, Citywest Business Campus, Dublin 24
PA 0979/036/001
Date of first authorisation: 21 October 1986
Date of last renewal: 26 August 2006
| Drug | Countries | |
|---|---|---|
| DEQUADIN | Canada, Hong Kong |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
